BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 12189151)

  • 1. Malarial dihydroorotate dehydrogenase. Substrate and inhibitor specificity.
    Baldwin J; Farajallah AM; Malmquist NA; Rathod PK; Phillips MA
    J Biol Chem; 2002 Nov; 277(44):41827-34. PubMed ID: 12189151
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of flavin oxidation and electron-transfer inhibition in Plasmodium falciparum dihydroorotate dehydrogenase.
    Malmquist NA; Gujjar R; Rathod PK; Phillips MA
    Biochemistry; 2008 Feb; 47(8):2466-75. PubMed ID: 18225919
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High-throughput screening for potent and selective inhibitors of Plasmodium falciparum dihydroorotate dehydrogenase.
    Baldwin J; Michnoff CH; Malmquist NA; White J; Roth MG; Rathod PK; Phillips MA
    J Biol Chem; 2005 Jun; 280(23):21847-53. PubMed ID: 15795226
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multiple inhibitor analysis of the brequinar and leflunomide binding sites on human dihydroorotate dehydrogenase.
    McLean JE; Neidhardt EA; Grossman TH; Hedstrom L
    Biochemistry; 2001 Feb; 40(7):2194-200. PubMed ID: 11329288
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recombinant expression of N-terminal truncated mutants of the membrane bound mouse, rat and human flavoenzyme dihydroorotate dehydrogenase. A versatile tool to rate inhibitor effects?
    Ullrich A; Knecht W; Fries M; Löffler M
    Eur J Biochem; 2001 Mar; 268(6):1861-8. PubMed ID: 11248707
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drosophila melanogaster dihydroorotate dehydrogenase: the N-terminus is important for biological function in vivo but not for catalytic properties in vitro.
    Löffler M; Knecht W; Rawls J; Ullrich A; Dietz C
    Insect Biochem Mol Biol; 2002 Sep; 32(9):1159-69. PubMed ID: 12213251
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biochemical characterization of recombinant dihydroorotate dehydrogenase from the opportunistic pathogenic yeast Candida albicans.
    Zameitat E; Gojković Z; Knecht W; Piskur J; Löffler M
    FEBS J; 2006 Jul; 273(14):3183-91. PubMed ID: 16774642
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibitor binding in a class 2 dihydroorotate dehydrogenase causes variations in the membrane-associated N-terminal domain.
    Hansen M; Le Nours J; Johansson E; Antal T; Ullrich A; Löffler M; Larsen S
    Protein Sci; 2004 Apr; 13(4):1031-42. PubMed ID: 15044733
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recent developments in the medicinal chemistry and therapeutic potential of dihydroorotate dehydrogenase (DHODH) inhibitors.
    Vyas VK; Ghate M
    Mini Rev Med Chem; 2011 Oct; 11(12):1039-55. PubMed ID: 21861807
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Species-related inhibition of human and rat dihydroorotate dehydrogenase by immunosuppressive isoxazol and cinchoninic acid derivatives.
    Knecht W; Löffler M
    Biochem Pharmacol; 1998 Nov; 56(9):1259-64. PubMed ID: 9802339
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Kinetics of inhibition of human and rat dihydroorotate dehydrogenase by atovaquone, lawsone derivatives, brequinar sodium and polyporic acid.
    Knecht W; Henseling J; Löffler M
    Chem Biol Interact; 2000 Jan; 124(1):61-76. PubMed ID: 10658902
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Functional expression of a fragment of human dihydroorotate dehydrogenase by means of the baculovirus expression vector system, and kinetic investigation of the purified recombinant enzyme.
    Knecht W; Bergjohann U; Gonski S; Kirschbaum B; Löffler M
    Eur J Biochem; 1996 Aug; 240(1):292-301. PubMed ID: 8925840
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Insight into the chemistry of flavin reduction and oxidation in Escherichia coli dihydroorotate dehydrogenase obtained by rapid reaction studies.
    Palfey BA; Björnberg O; Jensen KF
    Biochemistry; 2001 Apr; 40(14):4381-90. PubMed ID: 11284694
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of a biomarker to monitor target engagement after treatment with dihydroorotate dehydrogenase inhibitors.
    Pontikos MA; Leija C; Zhao Z; Wang X; Kilgore J; Tornesi B; Adenmatten N; Phillips MA; Williams NS
    Biochem Pharmacol; 2022 Oct; 204():115237. PubMed ID: 36055381
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structures of human dihydroorotate dehydrogenase in complex with antiproliferative agents.
    Liu S; Neidhardt EA; Grossman TH; Ocain T; Clardy J
    Structure; 2000 Jan; 8(1):25-33. PubMed ID: 10673429
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detergent-dependent kinetics of truncated Plasmodium falciparum dihydroorotate dehydrogenase.
    Malmquist NA; Baldwin J; Phillips MA
    J Biol Chem; 2007 Apr; 282(17):12678-86. PubMed ID: 17329250
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dihydroorotate dehydrogenase is a high affinity binding protein for A77 1726 and mediator of a range of biological effects of the immunomodulatory compound.
    Williamson RA; Yea CM; Robson PA; Curnock AP; Gadher S; Hambleton AB; Woodward K; Bruneau JM; Hambleton P; Moss D; Thomson TA; Spinella-Jaegle S; Morand P; Courtin O; Sautés C; Westwood R; Hercend T; Kuo EA; Ruuth E
    J Biol Chem; 1995 Sep; 270(38):22467-72. PubMed ID: 7673235
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biochemical and molecular characterization of the pyrimidine biosynthetic enzyme dihydroorotate dehydrogenase from Toxoplasma gondii.
    Hortua Triana MA; Huynh MH; Garavito MF; Fox BA; Bzik DJ; Carruthers VB; Löffler M; Zimmermann BH
    Mol Biochem Parasitol; 2012 Aug; 184(2):71-81. PubMed ID: 22580100
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel inhibitors of Plasmodium falciparum dihydroorotate dehydrogenase with anti-malarial activity in the mouse model.
    Booker ML; Bastos CM; Kramer ML; Barker RH; Skerlj R; Sidhu AB; Deng X; Celatka C; Cortese JF; Guerrero Bravo JE; Crespo Llado KN; Serrano AE; Angulo-Barturen I; Jiménez-Díaz MB; Viera S; Garuti H; Wittlin S; Papastogiannidis P; Lin JW; Janse CJ; Khan SM; Duraisingh M; Coleman B; Goldsmith EJ; Phillips MA; Munoz B; Wirth DF; Klinger JD; Wiegand R; Sybertz E
    J Biol Chem; 2010 Oct; 285(43):33054-33064. PubMed ID: 20702404
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Purification and characterization of Plasmodium falciparum succinate dehydrogenase.
    Suraveratum N; Krungkrai SR; Leangaramgul P; Prapunwattana P; Krungkrai J
    Mol Biochem Parasitol; 2000 Feb; 105(2):215-22. PubMed ID: 10693744
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.